MEDevice Silicon Valley: Generative AI in Product Development
On November 20, 2024, James Fox, Vice President of Business Development at StarFish Medical, will join an expert panel discussion titled “Generative AI in Product Development – Staying on Top of an Accelerating Space” at MEDevice Silicon Valley. This session, part of the AI/Machine Learning track, will explore how generative AI is revolutionizing modern product development processes.
The panel will feature insights from industry leaders, including Michelle Wu, CEO & Co-founder at NyquistAI, and Scott Thielman, CTO at Product Creation Studio. Together, they will discuss real-world applications of generative AI, transformative tools, and strategies to integrate these technologies into product development workflows.
Key Learning Objectives:
- Future of AI in Product Development: Learn strategies to stay ahead in this rapidly evolving space and leverage AI for competitive advantage.
- Understanding Generative AI: Gain a comprehensive overview of advancements in generative AI and its role in product development.
- Practical Applications: Explore case studies demonstrating the impact of generative AI tools on accelerating workflows and achieving innovative outcomes.
About MEDevice Silicon Valley 2024
MEDevice Silicon Valley 2024 is the Region’s Epicenter for Innovation and brings engineers, business leaders, disruptive companies, and innovative thinkers from the region’s top start-ups and medical device OEMs together to inspire the next life-changing medical device. It provides the platform for taking an innovative solution from a concept to a full-fledged product by bringing together the brightest minds in 3D printing, digital health, surgical robotics, and more.
- 1,200+ attendees
- 170+ exhibitors
- 40 industry speakers and thought leaders
Presenter Bios:
James Fox
James Fox is an engineer, growth strategist, and business development professional. A founder of a medical device start-up operating in point of care diagnostics, he also has technical leadership experience in large corporate and consultative environments, with crossover experience in the highly regulated aerospace and industrial robotics spaces. James supports clients in finding pathways to solve critical technical challenges, aligning development strategies to funding and market needs, and in delivering transformative results for patients.